BioBridgeXAll companies

Pelthos Therapeutics Inc.

Biotechnology company · Durham, North Carolina, United States · NYSE: PTHS

Pelthos Therapeutics Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2021. Its shares trade on NYSE under the ticker PTHS. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Pelthos Therapeutics at a glance

Typebiotechnology company
HeadquartersDurham, North Carolina, United States
Earliest incorporation on record2021
Stock listingNYSE: PTHS
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1919246

What does Pelthos Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $18 million sold (2025).

Frequently asked questions about Pelthos Therapeutics

Where is Pelthos Therapeutics headquartered?

Pelthos Therapeutics Inc. is headquartered in Durham, North Carolina, United States.

What does Pelthos Therapeutics do?

Pelthos Therapeutics Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Pelthos Therapeutics a public company?

Yes. Pelthos Therapeutics Inc. trades on NYSE under the ticker PTHS.

When was Pelthos Therapeutics founded?

The earliest incorporation on record for Pelthos Therapeutics Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences